Thrombolytic therapeutic drugs occupy an essential position in
cardiovascular treatment market, therefore pharma manufacturers attach great
importance to cooperating with a professional Urokinase manufacturer. Urokinase
is a serine protease extracted from human urine, applied for developing drugs
targeting thrombus‑related clinical conditions. Product purity, specific
activity and virus safety are three core evaluation indicators for this
biological API.
Procurement teams often face troubles including unstable specific‑activity
value, high foreign‑protein residue, incomplete virus‑validation records. A
qualified Urokinase manufacturer must build full‑chain quality management
covering raw‑material source control, multi‑step purification, virus
inactivation and comprehensive release testing. Kangyuan, as a biological API
producer in Qingdao, has accumulated rich practical experience on
urinary‑derived enzyme product production.
As a dedicated Urokinase manufacturer, Kangyuan strictly monitors key
indicators such as specific activity, protein impurities, endotoxin level and
virus safety for every production batch. We support small‑quantity R&D
sample orders and large‑volume commercial manufacturing supply. All batches come
with complete audit‑ready documentation for global pharmaceutical partners’
regulatory filing and factory inspection.
Our QA and R&D group can respond to your questions about product
specifications, lyophilization characteristics and storage requirements. If your
project needs trustworthy urokinase API source, please contact Kangyuan for
quotation and sample application.